Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Gains from Sales and Divestitures (2010 - 2020)

InfuSystem Holdings posted quarterly Gains from Sales and Divestitures of $28432.0 for Q4 2020, down 51.24% year-on-year from $58314.0 in Q1 2020, and down 51.24% on a QoQ basis from $58314.0 in Q4 2019.

InfuSystem Holdings (INFU) has 11 years of Gains from Sales and Divestitures data on file, last reported at $28432.0 in Q4 2020.

  • For the quarter ending Q4 2020, Gains from Sales and Divestitures fell 51.24% year-over-year to $28432.0; the trailing twelve-month figure through Dec 2020 stood at $28432.0 (down 51.24% YoY), and the FY2020 full-year result was $28432.0, down 51.24% from the prior year.
  • Gains from Sales and Divestitures for Q4 2020 stood at $28432.0, down from $58314.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $100000.0 in Q1 2019 and bottomed at $4116.0 in Q4 2018.
  • The 5-year median for Gains from Sales and Divestitures is $43373.0 (2019), against an average of $45129.0.
  • The widest annual swing landed in 2017, when Gains from Sales and Divestitures plunged 75.49%; it then surged 1316.76% in 2019.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $64182.0 in 2016, then slumped by 75.49% to $15730.0 in 2017, then sank by 73.83% to $4116.0 in 2018, then soared by 1316.76% to $58314.0 in 2019, then sank by 51.24% to $28432.0 in 2020.
  • The last three Gains from Sales and Divestitures figures came in at $28432.0 (Q4 2020), $58314.0 (Q4 2019), and $100000.0 (Q1 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 InfuSystem Holdings 200.09 Mn 197.98 Mn 19.68 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 28,432.00
Dec 31, 2020 28,432.00
Dec 31, 2019 58,314.00
Dec 31, 2019 58,314.00
Mar 31, 2019 100,000.00
Mar 31, 2019 100,000.00
Dec 31, 2018 4,116.00
Dec 31, 2018 4,116.00
Dec 31, 2017 15,730.00
Dec 31, 2017 15,730.00
Dec 31, 2016 64,182.00
Dec 31, 2016 64,182.00
Dec 31, 2015 83,029.00
Dec 31, 2015 83,029.00
Dec 31, 2014 128,000.00
Dec 31, 2014 128,000.00
Dec 31, 2013 168,000.00
Dec 31, 2013 168,000.00
Dec 31, 2012 169,000.00
Dec 31, 2012 169,000.00
Mar 31, 2012 -151,000.00
Mar 31, 2012 -151,000.00
Dec 31, 2011 -2.12 Mn
Dec 31, 2011 -2.12 Mn
Sep 30, 2011 -1.32 Mn
Sep 30, 2011 -1.32 Mn
Jun 30, 2011 -523,000.00
Jun 30, 2011 -523,000.00
Mar 31, 2011 -271,000.00
Mar 31, 2011 -271,000.00
Dec 31, 2010 -484,000.00
Dec 31, 2010 -484,000.00
Sep 30, 2010 -331,000.00
Sep 30, 2010 -331,000.00